MTRR rs1801394: Understanding the A66G Genetic Variant
The MTRR rs1801394 variant, commonly known as A66G or Ile22Met, is a single-nucleotide polymorphism in the methionine synthase reductase gene. It is frequently studied for its potential role in folate and homocysteine metabolism, though its clinical significance remains a subject of ongoing research.
What each genotype means
Typical enzyme activity
This genotype represents the most common form of the MTRR gene, often referred to as the wild-type or reference sequence. Research suggests this version of the enzyme functions at standard efficiency to support the recycling of vitamin B12 in folate metabolism. No specific health risks are definitively linked to this genotype alone.
This is the most common genotype in many populations, though frequencies vary significantly by ancestry.
Reduced enzyme activity
Carrying one copy of the G allele, also known as the A66G variant, may result in a modest reduction in the efficiency of the methionine synthase reductase enzyme. While this can influence how your body recycles vitamin B12 to manage homocysteine levels, the impact is generally considered subtle and may be more relevant when combined with low B-vitamin status or other genetic factors. Discuss your nutritional status and any concerns regarding homocysteine levels with your healthcare provider.
This heterozygous genotype is very common, found in a large share of the global population.
Lower enzyme activity
This genotype results in two copies of the G allele, which is associated with a more pronounced decrease in methionine synthase reductase activity compared to the AA genotype. Some studies have explored potential links between this variant and a slightly increased susceptibility to certain health conditions, including specific types of cancer, though the evidence remains limited and inconsistent. Because this variant affects folate and homocysteine metabolism, you should consult with a clinician or registered dietitian to ensure your B-vitamin intake is appropriate for your needs.
This genotype is present in a significant portion of the population, with a minor allele frequency for G typically ranging between 0.40 and 0.55 in European descent populations.
What is the rs1801394 Variant?
The rs1801394 variant is a common genetic change located within the MTRR gene, which sits on chromosome 5. In this specific variant, an adenine (A) nucleotide is replaced by a guanine (G) nucleotide at position 66. This change results in an amino acid substitution where isoleucine is replaced by methionine at position 22 of the resulting protein, which is why it is often referred to as Ile22Met. Because this is a single-nucleotide polymorphism (SNP), it is a natural variation found in the human genome. While it is a well-documented genetic marker, it is important to understand that having this variant does not mean an individual has a disease or a medical condition. It is simply one of many variations that contribute to the genetic diversity observed across human populations.
The Role of the MTRR Gene
The MTRR gene provides the instructions for creating an enzyme called methionine synthase reductase. This enzyme plays a critical role in the body's methylation cycle, a complex biochemical process necessary for DNA synthesis, repair, and the regulation of gene expression. Specifically, methionine synthase reductase is responsible for 'recharging' another enzyme called methionine synthase. Methionine synthase requires this reactivation to function properly, as it helps convert the amino acid homocysteine into methionine. By maintaining the activity of methionine synthase, the MTRR enzyme indirectly supports the balance of homocysteine levels in the blood. When the MTRR enzyme is less efficient, it may theoretically impact the efficiency of this recycling process, which is why researchers have spent decades investigating how this specific variant might influence metabolic health and various physiological outcomes.
Research Associations and Evidence Strength
Research into rs1801394 has produced a wide range of findings, leading to a complex and sometimes contradictory body of evidence. Many studies have explored whether this variant is associated with an increased risk for conditions such as neural tube defects, cardiovascular issues, and various types of cancer. While some meta-analyses have suggested a statistical association with an increased overall cancer risk, these findings are often inconsistent across different ethnic groups and study designs. For example, some research indicates that the variant might interact with environmental factors, such as alcohol consumption or folate intake, to influence health outcomes. Because of these mixed results and the lack of large-scale, definitive clinical trials, the evidence linking this variant to specific health outcomes is considered limited. It is essential to view these statistical associations as population-level observations rather than individual medical predictions.
What You Can and Cannot Do With This Information
Understanding your genotype for rs1801394 can be an interesting way to learn about your genetic makeup, but it is not a diagnostic tool. Because the evidence regarding the health impact of this variant is mixed and often context-dependent, it cannot be used to predict your personal health trajectory or to diagnose any condition. You should never use this information to make changes to your diet, supplement regimen, or medical care without consulting a qualified healthcare professional. If you are concerned about your homocysteine levels, folate status, or general metabolic health, the most effective approach is to discuss these topics with your doctor or a registered dietitian. They can order appropriate clinical blood tests to assess your actual physiological status, which is far more informative than looking at a single genetic variant in isolation.
How common is this variant?
The minor allele frequency for the G allele is approximately 0.40 to 0.55 in populations of European descent, making it a very common variant. Global frequencies can vary significantly, with some studies reporting frequencies around 49% to 56% in various Asian and other international cohorts.
Frequently asked questions
Is the MTRR A66G variant a cause for concern?
The MTRR A66G variant is a common genetic variation found in a large portion of the population. It is not a disease-causing mutation, and most people with this variant live healthy lives without any specific health issues related to it.
Should I take supplements if I have the MTRR GG genotype?
You should not start or change any supplement regimen based on your genotype alone. Always consult with your doctor or a pharmacist to determine if your specific health needs require supplementation, as they can evaluate your blood work and overall health status.
Does this variant affect my B12 or folate levels?
While the MTRR enzyme is involved in the recycling of B12 and folate metabolism, having the rs1801394 variant does not automatically mean you have a deficiency. Clinical blood tests are the only way to accurately measure your actual vitamin levels.
Can I use a DNA test to diagnose a health condition?
No, genetic variants like rs1801394 are not diagnostic. They represent statistical associations observed in research studies and cannot be used to predict or diagnose medical conditions in an individual.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801394?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29